Anzeige
Mehr »
Login
Donnerstag, 26.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000?% RENDITE!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XA9J | ISIN: FI4000074984 | Ticker-Symbol: 2VO
Tradegate
23.12.24
15:36 Uhr
22,910 Euro
-0,100
-0,43 %
1-Jahres-Chart
VALMET OYJ Chart 1 Jahr
5-Tage-Chart
VALMET OYJ 5-Tage-Chart
RealtimeGeldBriefZeit
22,97023,07023.12.
22,97023,04023.12.
PR Newswire
621 Leser
Artikel bewerten:
(2)

Valmet Oyj: Valmet receives the second order of converting lines to Metsä Tissue in Mariestad, Sweden

Finanznachrichten News

Valmet Oyj press release, June 19, 2024, at 9:30 a.m. EEST

ESPOO, Finland, June 19, 2024 /PRNewswire/ -- Valmet is to provide two complete tissue converting lines including packaging solutions to Metsä Tissue's mill in Mariestad, Sweden. The delivery includes digital services, training and support after the start-up. The order follows the earlier announced delivery of a Valmet Advantage DCT 200 tissue making line to the same mill. Both deliveries are part of Metsä Tissue's expansion and modernization project "The Future Mill", aiming at world-class environmental and operational performance.

The order of the two tissue converting lines was included in Valmet's orders received of the first quarter 2024. The value of the order will not be disclosed.

"We have a long history with Valmet and with the addition of converting technologies in their portfolio we clearly see the synergies with Valmet's end-to-end solution including tissue machine and converting lines. Their cutting-edge technologies and proven performance will ensure optimal production, a safer working environment and a more efficient tissue production," says Esa Paavolainen, Vice President Projects, Metsä Tissue.

"This is one of Valmet's first projects implementing the complete value chain, combining a Valmet tissue making line and converting technologies. It's a unique offering in the market. With it, we have developed a one-stop solution to actualize the integrated factory concept. We are proud to be part of Metsä Tissue's expansion journey," says Gianfranco Agnusdei, Vice President, Sales, Marketing and Services, Tissue Converting business unit, Paper business line, Valmet.

Delivery's technical information

The delivery comprises of two Valmet Perini Constellation tissue converting lines and the packaging machinery needed for the production of rolled tissue. The machinery represents latest technology for efficiency, flexibility, and low energy consumption.

Information about Metsä Tissue

Metsä Group's Tissue and Greaseproof Papers business, or Metsä Tissue, produces hygiene products for households and professionals, and greaseproof papers for food preparation and packaging. The 2023 sales were EUR 1.3 billion, and they have approximately 2,500 employees. Metsä Group's parent company Metsäliitto Cooperative is owned by around 90,000 Finnish forest owners.

VALMET
Corporate Communications

For further information, please contact:
Samppa Ahmaniemi, Vice President, Tissue Converting business unit, Paper business line, tel. +39 0583 460552, samppa.ahmaniemi@valmet.com

Gianfranco Agnusdei, Vice President, Sales, Marketing and Services, Tissue Converting business unit, Paper business line, tel. +39 0583 460900, gianfranco.agnusdei@valmet.com

Valmet is a leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries. With our automation systems and flow control solutions we serve an even wider base of process industries. Our more than 19,000 professionals around the world work close to our customers and are committed to moving our customers' performance forward - every day.

The company has over 220 years of industrial history and a strong track record in continuous improvement and renewal. Valmet's net sales in 2023 were approximately EUR 5.5 billion.

Valmet's shares are listed on the Nasdaq Helsinki and the head office is in Espoo, Finland.

Follow us on valmet.com | X | X (IR) | LinkedIn | Facebook | YouTube | Instagram |

Processing of personal data

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/valmet-oyj/r/valmet-receives-the-second-order-of-converting-lines-to-metsa-tissue-in-mariestad--sweden,c4003450

Cision View original content:https://www.prnewswire.co.uk/news-releases/valmet-receives-the-second-order-of-converting-lines-to-metsa-tissue-in-mariestad-sweden-302176550.html

© 2024 PR Newswire
6 Richtige für 2025
Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.